Search results for "concomitant"

showing 10 items of 248 documents

Cornea in acromegalic patients as a possible target of growth hormone action.

2010

Background: GH exerts its effects on many organs and the eye also seems to be a target site, although few authors have investigated the corneal thickness in patients with acromegaly. Aim: To perform a detailed ophthalmological evaluation in acromegalic patients, in relation to disease activity. Material and methods: Twenty-eight acromegalic patients (11 males, 17 females) and 22 voluntary healthy subjects underwent complete metabolic and ophthalmological evaluation, including retinal thickness (RT), central corneal thickness (CCT), and intraocular pressure values (IOP). Results: Significantly greater CCT values were found in all acromegalic patients in comparison with controls (567 vs 528.5…

Malemedicine.medical_specialtyIntraocular pressureacromegaly corneagenetic structuresEndocrinology Diabetes and MetabolismOcular hypertensionGrowth hormoneSettore MED/13 - EndocrinologiaCorneaBasal (phylogenetics)chemistry.chemical_compoundEndocrinologyCorneaInternal medicineOphthalmologyAcromegalymedicineAnimalsHumansIntraocular PressureMetabolic SyndromeSettore MED/30 - Malattie Apparato Visivobusiness.industryHuman Growth HormoneRetinalMiddle Agedmedicine.diseaseeye diseasesmedicine.anatomical_structureEndocrinologychemistryConcomitantAcromegalyFemaleOcular Hypertensionsense organsbusiness
researchProduct

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Resul…

2018

Abstract Background and purpose Standard treatment of epidermoid anal cancer is 5-fluorouracil (5FU) and mitomycin C (MMC) based chemoradiotherapy (CRT). This phase I study aims to evaluate the addition of panitumumab (Pmab) to CRT and to determine the maximum tolerated dose (MTD) of Pmab and 5-FU in combination with CRT. Materials and methods Immunocompetent patients with locally advanced tumour without metastases (Stage T2, T3 or T4, whatever N stage; Stage N1–N3 whatever T stage) followed two RT periods (45 Gy in 5 weeks and 20 Gy in 2 weeks, separated by a 2-week break) with concomitant CT sessions of 5FU/MMC at RT weeks 1, 5 and 8. Pmab was administered on RT weeks 1, 3, 5, 8 and 10 ac…

Malemedicine.medical_specialtyMitomycinUrologyPhases of clinical research030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAnal cancerPanitumumabRadiology Nuclear Medicine and imagingProspective StudiesAgedbusiness.industryPanitumumabStandard treatmentMitomycin CChemoradiotherapyHematologyMiddle AgedAnus Neoplasmsmedicine.diseaseErbB ReceptorsOncology030220 oncology & carcinogenesisConcomitantT-stageFemaleFluorouracilbusinessChemoradiotherapymedicine.drugRadiotherapy and Oncology
researchProduct

Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study

2018

Background/objective The study aimed to analyze the frequency of partial remission (PR) and its association with chosen clinical and laboratory factors among pediatric patients with newly diagnosed type 1 diabetes (T1D). The long-term effect of PR on chosen parameters was also investigated. Methods In 194 patients (95 girls) aged 8.1 ± 4.3 years, we analyzed data at T1D onset: glycemia, pH, C-peptide, antibodies, weight, and concomitant autoimmune diseases. Anthropometric parameters, daily insulin requirement (DIR), and HbA1c 2 and 4 years after T1D diagnosis were also analyzed. We determined PR based on HbA1c and DIR measurements at least every 3 months. Results PR occurred in 59% of patie…

Malemedicine.medical_specialtyMultivariate analysisAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismGastroenterologyDiabetic Ketoacidosis03 medical and health sciences0302 clinical medicineInternal medicineRemission phaseInternal MedicinemedicineHumans030212 general & internal medicineAge of OnsetChildGlycated HemoglobinType 1 diabetesbusiness.industryInsulinRemission InductionAge Factorsmedicine.diseaseKetoacidosisDiabetes Mellitus Type 1Child PreschoolConcomitantPediatrics Perinatology and Child HealthFemaleObservational studyPolandbusinessBody mass indexPediatric Diabetes
researchProduct

Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-α in pancreatic and periampullary cancer: Results of a feasibility study

2008

Abstract Background Recent studies give rise to the hypothesis, that adjuvant chemoradioimmunotherapy with 5-fluorouracil (5-FU), cisplatin and interferon-α (IFN-α) might be a possible new treatment of pancreatic cancer in resected patients. We report the up-to-now experience at our institution. Patients and methods Eleven patients with histological diagnosis of localized carcinoma of the pancreas ( n  = 7) or periampullary ( n  = 4) were prospectively analyzed. Four patients were deemed unresectable because of local invasion of adjacent organs (neoadjuvant setting) and seven patients underwent curative resection (adjuvant setting). Eight patients were classified as T3 carcinomas and three …

Malemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentAntineoplastic AgentsRisk AssessmentGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinePancreatic cancermedicinePeriampullary cancerHumansNeoplasm InvasivenessRadiology Nuclear Medicine and imagingSurvival rateNeoplasm Staging030304 developmental biology0303 health sciencesbusiness.industryPatient SelectionRadiotherapy Dosagemedicine.diseaseCombined Modality Therapypeople.cause_of_deathRecombinant Proteins3. Good healthSurgeryPancreatic NeoplasmsSurvival RateRadiation therapyOncology030220 oncology & carcinogenesisConcomitantInterferon Type IFeasibility StudiesFemaleFluorouracilImmunotherapyCisplatinbusinesspeopleChemoradiotherapyProgressive diseaseCancer/Radiothérapie
researchProduct

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

2009

SUMMARY BACKGROUND: More and more people with severe hemophilia reach an old age thanks to an effective treatment. There is no information on the health status and quality of life of elderly people with hemophilia born at a time when replacement therapy was hardly available. METHODS: Italian patients with severe hemophilia, aged >or=65 years and hence born in 1942 or earlier, were compared with elderly men without bleeding disorders matched for age, sex, geography and social status. The following aspects were evaluated: concomitant illness, orthopedic status, physical functioning and cognitive status. Measurements of generic and disease-specific health-related quality of life were also obta…

Malemedicine.medical_specialtyPediatricshamophilia healt status agingActivities of daily livingHealth StatusPopulationActivities of Daily Living; Aged; Blood Coagulation Factors; Hemophilia A; Humans; Italy; Male; Health Status; Quality of LifeHemophilia ASettore MED/15 - Malattie Del SangueQuality of lifehemic and lymphatic diseasesArthropathyActivities of Daily LivingMedicineHumanseducationDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryHematologymedicine.diseaseBlood Coagulation FactorsItalyConcomitantOrthopedic surgeryPhysical therapyQuality of LifebusinessSocial status
researchProduct

Apparent Declining Prognostic Value of a Negative Stress Echocardiography Based on Regional Wall Motion Abnormalities in Patients With Normal Resting…

2019

Background: Cardiology guidelines identify the low-risk response during stress echocardiography as the absence of regional wall motion abnormalities. Methods: From 1983 to 2016, we enrolled 5817 patients (age 63±12 years; 2830 males) with suspected coronary artery disease, normal regional, and global left ventricular function at rest and during stress (exercise in 692, dipyridamole in 4291, and dobutamine in 834). Based on timing of enrollment, 4 groups were identified in chronological order of recruitment: years 1983 to 1989, group 1 (n=211); years 1990 to 1999, group 2 (n=1491); years 2000 to 2009, group 3 (n=3285); and years 2010 to 2016, group 4 (n=830). Results: There were 240 (4%) ev…

Malemedicine.medical_specialtyPopulationCoronary Artery Disease030204 cardiovascular system & hematologyVentricular Function LeftCohort StudiesCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusmedicineStress EchocardiographyHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineeducationReferral and Consultationeducation.field_of_studybusiness.industryHazard ratioReproducibility of ResultsMiddle AgedPrognosismedicine.diseaseDipyridamoleItalyConcomitantCardiologyFemaleDobutamineCardiology and Cardiovascular MedicinebusinessEchocardiography StressFollow-Up Studiesmedicine.drugCirculation: Cardiovascular Imaging
researchProduct

Does concomitant diabetes affect treatment responses in overactive bladder patients?

2013

Summary Aims To compare the efficacy and tolerability of a muscarinic receptor antagonist, darifenacin, in the treatment of overactive bladder (OAB) patients with concomitant diabetes as compared with those without comorbidities. Methods Post hoc exploratory analysis of a published, large, non-interventional study in OAB patients treated with darifenacin including 532 diabetics and 1315 controls. Associations of diabetes with treatment responses were evaluated by multiple regression models. Results Diabetics (largely type 2 patients) and controls differed in baseline age, body weight, duration of OAB symptoms and presence of comedications. However, they exhibited similar OAB symptom episode…

Malemedicine.medical_specialtyPyrrolidinesMuscarinic Antagonistsurologic and male genital diseasesAffect (psychology)Diabetes ComplicationsDiabetes mellitusInternal medicineMuscarinic acetylcholine receptorDarifenacinMedicineHumansBenzofuransDose-Response Relationship Drugbusiness.industryUrinary Bladder OveractiveAntagonistUrinary Bladder DiseasesGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsEndocrinologyTreatment OutcomeUrinary IncontinenceTolerabilityOveractive bladderConcomitantRegression AnalysisFemaleNocturiabusinessmedicine.drugInternational journal of clinical practice
researchProduct

Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients

2017

Background In hemodialysis (HD) patients, xerostomia and hyposalivation may intensify sensations of thirst, and contribute to the intake of fluids and excessive inter-dialytic weight gain (IWG). Since IWG is regarded to be higher in diabetic patients than in non-diabetics HD enhancing their mortality, it is crucial to define plausible underlying causes. Therefore, the study investigates factors contributing to the increased IWG in diabetic HD patients. Material and Methods The study included 97 HD patients (38 diabetics) receiving hemodialysis. All participants completed surveys comprising the Dialysis Thirst Inventory (DTI) and Xerostomia Inventory. Unstimulated whole saliva flow rate (USW…

Malemedicine.medical_specialtySalivaSodiummedicine.medical_treatment030232 urology & nephrologychemistry.chemical_elementWeight GainGastroenterologyXerostomiaThirst03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicineDiabetes mellitusMedicineHumansDiabetic NephropathiesGeneral DentistryDialysisbusiness.industryResearchSodium030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryOtorhinolaryngologychemistryConcomitantUNESCO::CIENCIAS MÉDICASKidney Failure ChronicSurgeryFemaleHemodialysismedicine.symptombusinessWeight gainThirst
researchProduct

A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study

2015

Superficial vein thrombosis (SVT) is commonly encountered in clinical practice. Recent studies have suggested that the concomitant presence of deep vein thrombosis (DVT) or pulmonary embolism (PE) at the time of SVT diagnosis is not uncommon, thus increasing the interest on this disease. Whether this coexistence is predicted by specific risk factors remains unknown.To evaluate potential risk factors for DVT coexistence in patients presenting with acute objectively diagnosed SVT of the lower limbs and to develop a simple score entirely based on clinical variables to define the pre-test probability of DVT in these patients.A multicenter, retrospective cohort study on SVT patients was conducte…

Malemedicine.medical_specialtySuperficial vein thrombosisDeep veinCohort StudiesMedicinePulmonary embolism; Risk factors; Saphenous vein; Ultrasonography; Venous thrombosis;Humanscardiovascular diseasesUltrasonographyRetrospective StudiesVenous Thrombosisbusiness.industryPulmonary embolismRetrospective cohort studyHematologySaphenous veinPulmonary embolism; Risk factors; Saphenous vein; Ultrasonography; Venous thrombosis; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Venous ThrombosisMiddle Agedmedicine.diseaseVenous thrombosiThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureRisk factorsConcomitantFemaleRadiologyRisk factorbusinessCohort study
researchProduct

Endovascular versus open surgical repair of abdominal aortic aneurysm with concomitant malignancy

2007

Background The management of patients with abdominal aortic aneurysm (AAA) and concurrent malignancy is controversial. This study retrospectively assessed the outcome of endovascular repair (EVAR) and open repair (OR) for the treatment of AAA in patients undergoing curative treatment for concomitant malignancies. Methods All patients who underwent surgery for a nonruptured infrarenal AAA of ≥5.5 cm and concomitant malignancy between 1997 and 2005 were retrospectively reviewed. Results Identified were 25 patients (22 men; mean age, 70.3 years) with nonruptured infrarenal AAA of ≥5.5 cm (mean size, 6.4 cm) and concomitant malignancy amenable for curative treatment. EVAR was used to treat 11 p…

Malemedicine.medical_specialtyTime FactorsTime FactorKaplan-Meier EstimateMalignancySettore MED/22 - Chirurgia VascolareFollow-Up StudieAortic aneurysmAneurysmPostoperative Complicationsabdominal aortic aneurysmRetrospective StudieNeoplasmsmedicineHumansEVARAgedRetrospective StudiesAged 80 and overbusiness.industryMortality rateOpen repairGreat BritainRetrospective cohort studyLength of StayMiddle Agedmedicine.diseaseAbdominal aortic aneurysmUnited KingdomSurgeryTreatment OutcomeItalyConcomitantNeoplasmFemaleSurgeryRadiologyPostoperative ComplicationbusinessCardiology and Cardiovascular MedicineVascular Surgical ProceduresAbdominal surgeryHumanAortic Aneurysm AbdominalFollow-Up StudiesmalignancyJournal of Vascular Surgery
researchProduct